Socioeconomic status is independently associated with overall survival in patients with multiple myeloma

References

• Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2006;56:106–130.
   PubMed Web of Science ®Google Scholar
• Blattner WA. Epidemiology of multiple myeloma and related plasma cell disorders: an analytic review. In: Potter M, editor. Progress in myeloma. New York, NY: Elseveier North Holland; 1980: pp 1–65.
   Google Scholar
• Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407–1427.
   PubMed Web of Science ®Google Scholar
• Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with special feature regarding survival. Cancer 2004;101:3–27.
   PubMed Web of Science ®Google Scholar
• Altekruse SF, Kosary Cl, Krapch M, et al. SEER Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute; 2010.
   Google Scholar
• Davey Smith G, Neaton JD, Wentworth D, et al. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 1998; 351:934–939.
   PubMed Web of Science ®Google Scholar
• Verma PS, Howard RS, Weiss BM. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. Am J Hematol 2008;83:355–358.
   PubMed Web of Science ®Google Scholar
• Saraf S, Chen YH, Dobogai LC, et al. Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplant 2006;34:1099–1102.
   Web of Science ®Google Scholar
• Modiano MR, Villar-Werstler P, Crowley J, et al. Evaluation of race as a prognostic factor in multiple myeloma: an ancillary of southwest oncology group study 8229. J Clin Oncol 1996;14:974–977.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Greipp PR, Jacobus S, et al. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol 2010;11:29–37.
   PubMed Web of Science ®Google Scholar
• Baris D, Brown LM, Silverman DT, et al. Socioeconomic status and multiple myeloma among US blacks and whites. Am J Public Health 2000;90:1277–1281.
   PubMed Web of Science ®Google Scholar
• Koessel SL, Theis MK, Vaughan TL, et al. Socioeconomic status and the incidence of multiple myeloma. Epidemiology 1996;7:4–8.
   PubMed Web of Science ®Google Scholar
• Clark DW, MacMahon B. The incidence of multiple myeloma. J Chronic Dis 1956;4:508–515.
   PubMedGoogle Scholar
• Savage D, Lindenbaum J, Van Ryzin J, et al. Race, poverty, and survival in multiple myeloma. Cancer 1984;54:3085–3094.
   PubMed Web of Science ®Google Scholar
• Renshaw C, Ketley N, Moller J, et al. Trends in the incidence and survival of multiple myeloma in South East England 1985–2004. BMC Cancer 2010;10:74.
   PubMed Web of Science ®Google Scholar
• Kristinsson SY, Derolf AR, Edgren G, et al. Socioeconomic differences in patient survival are increasing for acute myeloid leukemia and multiple myeloma in Sweden. J Clin Oncol 2009;27:2073–2080.
   PubMed Web of Science ®Google Scholar
• Pasqualetti P, Colantonio D, Collacciani A, et al. Socioeconomic status and survival in multiple myeloma. Minerva Med 1990; 81:713–716.
   PubMedGoogle Scholar
• Weston B, Grufferman S, MacMillan JP, et al. Effects of socioeconomic and clinical factors on survival in multiple myeloma. J Clin Oncol 1987;5:1977–1984.
   PubMed Web of Science ®Google Scholar
• Lenhard RE Jr, Enterline JP, Crowley J, et al. The effects of distance from primary treatment centers on survival among patients with multiple myeloma. J Clin Oncol 1987;5:1640–1645.
   PubMed Web of Science ®Google Scholar
• Abou-Jawde RM, Baz R, Walker E, et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica 2006;91:1410–1413.
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Creech C, Zequeira R, et al. Inclusion of comorbidity into oncology data registries. J Registry Manag 1999;26:66–70.
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973–2010 varying) - Linked To County Attributes - Total U.S., 1969–2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. Available from: www.seer.cancer.gov
   Google Scholar
• Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected finding from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20:417–435.
   PubMed Web of Science ®Google Scholar
• Islami F, Kahn AR, Bickell NA, et al. Disentangling the effects of race/ethnicity and socioeconomic status of neighborhood in cancer stage distribution in New York City. Cancer Causes Control 2013;24:1069–1078.
   PubMed Web of Science ®Google Scholar
• Bray C, Morrison DS, McKay P. Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland. Leuk Lymphoma 2008;49:917–923.
   PubMed Web of Science ®Google Scholar
• Gupta S, Wilejto M, Pole JD, et al. Low socioeconomic status is associated with worse survival in children with cancer: a systematic review. PloS One 2014;9:e89482.
   PubMed Web of Science ®Google Scholar
• Ojha RP, Prabhakar D, Evans E, et al. RE 10104: Abou-Jawde et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica 2006, 91:1410–1413. Haematologica 2007; 92:e46.
   PubMed Web of Science ®Google Scholar
• In H, Neville BA, Lipsitz SR, et al. The role of National Cancer Institute-designated Cancer Center status. Ann Surg 2012; 255:890–895.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, and risk stratification, and response assessment of multiple myeloma. Leukemia 2009;23:3–9.
   PubMed Web of Science ®Google Scholar